FDA inspection
Apozeal Pharmaceuticals Inc.: FDA inspection ending Apr 9, 2019
FDA inspection 1085686 · Official Action Indicated (OAI) · Levittown, PA
Key facts
| Inspection ID | 1085686 |
|---|---|
| Firm | Apozeal Pharmaceuticals Inc. |
| FEI number | 3004536846 |
| Address | 2091 Hartel Ave |
| City | Levittown |
| State | PA |
| ZIP | 19057 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Apr 9, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 584701 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data